Electromed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Electromed, Inc. (ELMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 4.99 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-25
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 4.99K shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2026 was 4.99K shares, a 31.02% decline from fiscal 2025.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 7.23K shares, a 68.67% decline from fiscal 2024.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 23.08K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-25 | 4.99K shares derived: sum of 3 quarters · filed 2026-08-25 | 4.99K shares 10-K · filed 2026-08-25 |
| 2026-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | 4.99K shares derived: sum of 2 quarters · filed 2026-05-12 | 4.99K shares 10-Q · filed 2026-05-12 | 5.52K shares derived: sum of 4 quarters · filed 2026-08-25 |
| 2025-12-31 | 4.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-10 | 4.99K shares 10-Q · filed 2026-02-10 | 5.52K shares derived: sum of 3 quarters · filed 2026-08-25 | |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 533.00 shares derived: sum of 2 quarters · filed 2026-08-25 | ||
| 2025-06-30 | 533.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | 7.23K shares 10-K · filed 2026-08-25 | ||
| 2025-03-31 | 6.70K shares 10-Q · filed 2025-05-13 | |||
| 2024-06-30 | 23.08K shares 10-K · filed 2025-08-26 | |||
| 2023-03-31 | 26.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | 40.13K shares derived: sum of 2 quarters · filed 2023-05-09 | 47.93K shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 13.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | 21.07K shares 10-Q · filed 2023-02-14 | ||
| 2022-09-30 | 7.80K shares 10-Q · filed 2022-11-08 | |||
| 2022-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | 4.54K shares derived: sum of 2 quarters · filed 2022-05-10 | 15.87K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 4.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | 15.87K shares 10-Q · filed 2022-02-08 | ||
| 2021-09-30 | 11.33K shares 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |